Background: Many authors advocate lipase as the preferred serological test for the diagnosis of
Introduction
Pancreatitis is an inflammatory disorder of the pancreas, the clinical course of which ranges from mild disease to multiple organ dysfunction and death. Guidelines for the diagnosis of pancreatitis commonly stipulate the presence of two of the three following criteria: typical abdominal pain; characteristic computed tomography (CT) findings, and/or amylase and/or lipase levels of three or more times the upper limit of normal (ULN).
1
The sensitivity and specificity of serum lipase for pancreatitis at a cut-off of three times the ULN range from 64% to 100% and from 99% to 100%, respectively. [2] [3] [4] [5] In comparison, at the same cut-off, the sensitivity and specificity of amylase range from 50% to 78.6% and from 99% to 100%. [2] [3] [4] [5] Lipase provides increased sensitivity in the diagnosis of acute pancreatitis caused by alcohol consumption, and also in patients presenting later in their clinical course.
6
Lipase is an enzyme that catalyses the breakdown of triglycerides. 7 In addition to pancreatic acinar cells, lipase is found in the gastrointestinal tract, including the oesophagus, duodenum, stomach and colon.
7 Lipase has also been described in the liver, heart, lungs and leukocytes. 7, 8 Pancreatic lipase content is approximately 100 times that of the small intestine and liver, and the pancreas to serum lipase concentration gradient is close to 20 000. 7 In addition to pancreatitis, mild lipase elevations above the ULN may be seen in a wide range of conditions, including peptic ulcer disease and other hepatobiliary disorders.
6 However, to the authors' knowledge, no previous study has systematically evaluated the aetiology of lipase levels of three or more times the ULN. Knowledge of the potential alternative causes of significantly raised lipase is essential for clinicians because such levels may be erroneously interpreted as indicative of pancreatitis in some cases. This is especially important as lipase is advocated as the preferred test for the diagnosis of pancreatitis in various guidelines and much weight is given to levels that exceed the ULN by three or more times. 1, 9 The literature was therefore reviewed for causes other than pancreatitis of lipase levels of three or more times the ULN. The objective of this review is not to suggest an alternative 'cut-off' for raised lipase, but, rather, to alert the clinician to other potential causes of significant lipase elevation (i.e. levels of three or more times the ULN) in order to facilitate more accurate interpretation and improve patient care.
Materials and methods

Eligibility criteria
The criteria for the inclusion of a study in this systematic review required the reporting article to have been published after 1985. Lipase levels of three or more times the ULN were defined as representing significant elevation. At least one patient must have clearly shown lipase levels of three or more times the ULN attributable to a cause other than pancreatitis, except in exceptional circumstances as outlined below. Review articles, conference abstracts and proceedings, and articles which made insufficient explanation for the lipase result(s) were excluded from data analysis.
Literature search
Using the keywords 'pancreatitis' , 'lipase' , 'amylase' and 'diagnosis' , the MEDLINE and EMBASE databases were searched for relevant articles published from 1985 to August 2013. Methods of lipase determination were initially labour-intensive and technically difficult, and more precise and faster assays were developed in the late 1980s; therefore, this study targeted articles published from 1985 onwards.
10-12 Additional searches were performed using MEDLINE and EMBASE based on manual checking of the reference lists from all appropriate articles. Any further studies were included if they met the inclusion criteria.
Study selection
Studies from the literature search were initially screened by reviewing article titles and abstracts. Studies were excluded if the review of the abstract identified any of the relevant exclusion criteria. When study inclusion based on article title and abstract was equivocal, the full text was reviewed and further screened for inclusion and exclusion criteria. Articles deemed suitable for inclusion were independently assessed by two reviewers before a final decision on study eligibility was made.
Data collection
A standardized table was utilized in the process of extracting data from each article. The information collected from each study included: author(s); study year; city(s)/country(s) of study; number of patients in the series (including numbers with elevated lipase, and numbers with lipase levels of three or more times the ULN); normal ranges of lipase and amylase; mean peak lipase levels; mean peak amylase levels; evidence of pancreatitis in CT and/or ultrasonography (US); presence of abdominal pain or tenderness; method(s) used to confirm diagnosis, and condition(s) associated with lipase levels of three or more times the ULN as cited in the article (Appendix). Obvious confounders, such as alcoholism or renal failure, were noted. Individual patients in whom these confounders coexisted with the cause under investigation were generally excluded, except in studies outlining renal failure or alcoholism as potential causes of significant lipase elevation.
Causes of lipase of three or more times the ULN in each study were categorized as either (i) 'probable' or (ii) 'possible' . These two groups were defined according to: (i) the number of study(s) supporting the cause of raised lipase; (ii) the strength of confirmatory evidence, such as cross-sectional imaging, laparotomy/ surgical findings and/or specific serological or other tests; (iii) the possibility of underlying subclinical pancreatitis based on the mechanism in question, and/or (iv) the presence or absence of other potential causes of raised lipase.
Formulation of results
Qualitative items from each study, primarily representing different causes of lipase levels of three or more times the ULN, were synthesized and divided into four final groups: (i) reduced clearance or physiological causes; (ii) intra-abdominal pancreatic and non-pancreatic causes; (iii) critical illness, and (iv) other. Neither a quantitative analysis nor a formal meta-analysis could be conducted as a result of the significant heterogeneity among the articles and because of the inclusion of case reports in the final analysis. This systematic review was completed in line with PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines.
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Results
The process of study selection and exclusion is outlined in Fig. 1 . Data from 58 studies were included in the final qualitative analysis from which probable causes other than pancreatitis for lipase levels of three or more times the ULN were drawn.
Three of the 58 articles indicated potential associations with lipase levels of three or more times or close to three times the ULN without conclusive evidence (Table 1) . Table 2 summarizes all potential causes of lipase levels of three or more times the ULN without associated pancreatitis, categorized into the four groups outlined above. The strength of evidence for each alternative cause is also outlined in Table 2 .
Alternative causes of lipase levels of three or more times the ULN Reduced lipase clearance/physiological causes There is no correlation between the cause of acute kidney injury (AKI) and raised lipase.
14-16
Intra-abdominal non-pancreatic and pancreatic causes (non-traumatic) Hepatocellular carcinoma, bowel cancer with liver metastases and unspecified metastatic bowel and gastric cancer can all be considered as possible causes of lipase levels of three or more times the ULN. 11, 14, 17 Patients with these diagnoses in the respective series often had a normal pancreas on US and/or CT scanning, and a negative laparotomy when performed (Appendix).
Non-pathological pancreatic hyperenzymaemia is a more recently described phenomenon with good evidence as a cause of significant lipase elevation. [18] [19] [20] [21] [22] It is characterized by the absence of identifiable pancreatic disease in the presence of elevated pancreatic enzyme levels.
23
Elevated lipase levels may also be seen post-endoscopic retrograde cholangiopancreatography (ERCP), without any associated evidence of pancreatitis.
24 Gottlieb et al. showed that lipase levels of 1000 units/l (normal range: 40-240 units/l) after ERCP had Figure 1 Study selection process. ULN, upper limit of normal specificity of only 55% for pancreatitis. 24 The existence of foci of pancreatitis cannot be disproved, however, and the clinical significance of this lipase rise is uncertain.
Lipase in critical illness
Multi-trauma patients without head injury have been reported to have significant lipase elevations without strong radiological or operative evidence for pancreatitis. 8, 11, [25] [26] [27] Broadly, these patients have sustained blunt abdominal or pelvic trauma, in some cases with associated liver injury. 8, 11, 25, 27 However, it is very difficult to disprove underlying subclinical pancreatitis in such patients, and therefore multi-trauma cannot be thought of as a probable cause of lipase levels of three or more times the ULN without pancreatitis.
Some authors have also pointed to lipase elevations of three or more times the ULN in non-surgical intensive care unit (ICU) patients with such diagnostic categories as septic shock and respiratory failure; underlying pancreatitis remains a significant possibility here (Table 3) . 25, 26 Other causes of lipase levels of three or more times the ULN Diabetes Malloy et al. showed that a very small proportion of patients with asymptomatic type 2 diabetes had lipase levels of three or more times the ULN; this may thus be a possible cause of significant lipase elevation.
28
Abdominal pain is a common finding in diabetic ketoacidosis (DKA); however, in the studies outlined in Table 2, 29-33 DKA patients with elevated lipase and abdominal pain rarely showed clinical and/or radiological pancreatitis (see also Appendix).
Drugs Despite the association of chronic alcoholism with chronic pancreatitis, some authors have shown lipase levels of three or more times the ULN in otherwise asymptomatic alcoholics.
34
Some patients also experienced significant abnormalities in serum lipase after the administration of the dipeptidyl peptidase-4 (DPP-4) inhibitors, sitagliptin and saxagliptin, for the treatment of type 2 diabetes.
35 None of these patients had clinical features of pancreatitis and lipase levels normalized in most after drug withdrawal. 35 Lobo et al. used intramuscular morphine (10 mg) and prostigmine (1 mg) for the investigation of sphincter of Oddi dysfunction (SOD).
36 Surprisingly, both patients with proven SOD and healthy controls showed a lipase rise that sometimes exceeded three times the ULN. 36 Provocation did not induce pain in any of the healthy controls.
36
Infection Yoffe et al. found that some asymptomatic patients with chronic hepatitis C virus (HCV) infection demonstrated lipase levels of three or more times the ULN; lipase levels often normalized in patients who responded to HCV therapy. 37 Patients with human immunodeficiency virus (HIV) may also sometimes develop high lipase levels, although the contribution of the virus alone to this abnormality is debatable and at best possible.
38 Gastroenteritis is also a possible consideration in patients with elevated lipase without pancreatitis, but more evidence is required.
11,15
Miscellaneous causesSarcoidosis has been reported in a single case as a possible cause of lipase levels of three or more times the ULN. 39 This patient had no clinical or imaging features of pancreatitis. 39 Coeliac disease and inflammatory bowel disease (IBD) were associated with lipase elevations that came close to but did not reach three or more times the ULN [40] [41] [42] (Table 1) .
Discussion
Summary of evidence
This systematic, qualitative review has outlined a wide variety of causes of lipase levels of three or more times the ULN with the purpose of significantly aiding the clinician in his or her interpretation of this result. Although the specificity of lipase testing for pancreatitis at a cut-off of three or more times the ULN is >99%, it is essential for health care providers to understand other potential causes of this abnormality.
2-5
As Table 2 shows, there are many potential causes other than pancreatitis for the significant elevation of lipase levels. Reduced clearance of lipase from the circulation can occur with renal impairment or macrolipase formation. Lipase may also be elevated as a result of other intra-abdominal pathologies arising from the stomach, bowel and hepatobiliary tract, and from neoplastic disease. Diabetes, drugs and infection can also be responsible for lipase levels of three or more times the ULN. Table 3 explains the possible pathogeneses of some of these causes of elevated serum lipase.
Data bias and study limitations
As a result of the heterogeneous nature of the studies included, and often insufficient and poorly comparable quantitative data, a See text. Possible causes of significantly raised lipase, as defined in the Methods section, are denoted by a preceding '?'. 'Blood tests' as one method of confirming a diagnosis implies the use of standard accepted serological tests for each respective condition (if applicable). Clinical assessment is by implication a part of diagnosis confirmation, and is thus not explicitly mentioned. AAA, abdominal aortic aneurysm; AKI, acute kidney injury; CMV, cytomegalovirus; CRF, chronic renal failure; CT, computed tomography; DKA, diabetic ketoacidosis; DM, diabetes mellitus; DPP-4, dipeptidyl peptidase-4; ERCP, endoscopic retrograde cholangiopancreatography; HCV, hepatitis C virus; HIDA, hepatobiliary iminodiacetic acid; HIV, human immunodeficiency virus; ICH, intracranial haemorrhage; Ig, immunoglobulin; MRCP, magnetic resonance cholangiopancreatography; MRCP-S, secretin-enhanced MRCP; MRI, magnetic resonance imaging; NR, not recorded; TBI, traumatic brain injury; US, ultrasonography.
quantitative analyses were not performed here. Some of the proposed causes of lipase levels of three or more times the ULN are at best speculative, but every effort has been made to include only those causes for which there are plausible mechanism(s) and for which there exists evidence from multiple sources. An attempt was made in the data collection process to account for underlying conditions that may confound lipase values, such as alcoholism and the presence of renal impairment. Although the methods by which diagnoses were confirmed were recorded, there will inevitably be cases in which underlying mild pancreatic inflammation may have been missed in the respective studies; this is especially likely in retrospective series. 15 Normal findings in CT, ERCP, US and even laparotomy may not always preclude histological pancreatitis. [43] [44] [45] Indeed, the CT scan may be normal in up to 25% of patients with clinical pancreatitis.
30,46
Lipase assays It is important for clinicians to understand that assay interference and the detection of non-pancreatic lipases is possible; this in itself will not usually produce levels of three or more times the ULN, but can definitely alter lipase results. 7, 47 Demanet et al., for example, showed large increases in serum lipase after the administration of i.v. heparin to patients; the Ektachem and Wako assays were used in this study. 48 When assay interference is suspected, clinicians should contact their clinical chemistry laboratory for clarification.
Implications and future perspectives Lipase remains a good serological test for the diagnosis of pancreatitis. However, as shown by this study, levels of three or more times the ULN do not automatically confirm the diagnosis and many possible differential diagnoses exist. The diagnosis of • Presence of macrolipase may sometimes indicate an increased risk for associated disorders, such as autoimmune or lymphoproliferative disease 51, 52 Intra-abdominal pancreatic and non-pancreatic causes (other than pancreatitis)
• Inflammation: pancreas probably highly sensitive to inflammation in adjacent organs/structures, such as the biliary tract and gastrointestinal tract, with subsequent increases in serum lipase caused by inflammation of these organs 11, 43 • Obstruction: biliary regurgitation into the pancreas from distal obstruction may induce pancreatic inflammation; biliary, pancreatic duct or bowel obstruction may also cause increased bloodstream diffusion of pancreatic enzymes 4, 11, 14 • Alternative sources of lipase: stomach, small bowel, liver, gallbladder and other surrounding organs may potentially act as non-pancreatic sources of lipolytic enzymes 14
• Peritonitis: mechanisms not clear with regards to peritoneal irritation (e.g. intra-abdominal haemorrhage) and elevated serum lipase 65 • Impaired hepatic function: reduced hepatic metabolism of lipase may occur with impaired hepatic function (e.g. chronic liver diseases like biliary atresia) 57, 74 • Neoplasia: lipase elevation may be related to biliary or pancreatic ductal obstruction, formation of macrolipases, or (functional) tumour mass lipase production/hypersecretion 17, 60, 62 • Non-pathological pancreatic hyperenzymaemia: mechanisms not yet characterized, although a genetic basis should be entertained 23 
Critical illness
• ICU patients with critical illness/multi-organ failure: pancreatic hypoperfusion with cellular stress may be responsible for lipase elevations; 25 alternatively, pancreatic enzymes in the gut may enter the submucosa and subsequently the systemic circulation during times of gut ischaemia from reduced splanchnic flow 25, 26 • Neurosurgical patients with severe head injuries: exocrine pancreatic enzyme production may be activated through central pathways, such as increased vagal tone, altered adrenergic stimulation, and/or release of activating hormones such as cholecystokinin 66, 68 Some alternative causes
Diabetic ketoacidosis and type I DM
• Possible causes of raised lipase in DKA: may include relative renal hypoperfusion and thus reduced serum clearance of the enzyme; 30 alternatively, impaired pancreatic and/or splanchnic flow, in addition to non-pancreatic release of lipolytic enzymes, may be contributing factors. 17, 54, 56 • In DKA and recent-onset type 1 DM in general: inflammation from immune-mediated β-cell destruction could potentially 'spill over' into the exocrine pancreas, with subsequent acinar cell damage 14, 30, 70 CRF, chronic renal failure; DKA, diabetic ketoacidosis; DM, diabetes mellitus; ICU, intensive care unit.
pancreatitis based on clinical and serological features will sometimes generate false positives as many of the alternative diagnoses described in the current review also present with abdominal pain.
In less clear circumstances, the simultaneous measurement of both amylase and lipase should also be considered, although many authors doubt that this practice enhances diagnostic accuracy.
1,2,6,15 Furthermore, the conditions presented here as causing lipase levels of three or more times the ULN often also induce elevations of serum amylase, which may negate any added diagnostic utility afforded by amylase measurement.
6 Alternative serological tests may refer to amylase isoenzymes, immunoreactive trpysinogen (IRT) and elastase-1. 6 The latter two tests offer little help over lipase or amylase as routine diagnostic tests for pancreatitis, although they may be helpful in the event that a diagnosis of pancreatitis is doubtful. 6 Another potential course of action in cases of diagnostic difficulty is to lower the threshold for abdominal CT, which may pick up alternative causes for the patient's presentation.
Overall, elevated lipase levels, like raised amylase levels, can occur in both asymptomatic patients and patients with a myriad of differing medical and surgical conditions. Knowledge of these different aetiologies will aid clinicians in the decision making and treatment of patients with significantly raised lipase, especially in patients with equivocal lipase levels.
Conflicts of interest
None declared. 
Appendix Study data
Author ( 
